Reddit Posts
Looking for Legitimate/Successfully used Stock Signal Notifications
Feetr Data Dump: PXMD FRC PYXS MCB CRKN INPX PALI
$PALI $50 price target. Currently 2.2s
$SILO 'Silo Pharma Inc' squeeze potential
Has anyone been looking at the short int for PALI? Thoughts?
Low Float PALI Stock Buyers Drive Up Its Price So High.
💰💰💰Good morning! #premarket #watchlist 12/30 $PALI -old news+big volume(+96%), $TUEM -old news+big volume(+68%), $KALA -old news+legendary runner (+43%), $DRMA - no news+big volume(+90%)
PALI stock, is there an opportunity here to exploit?
New opportunity! PALI stock, super low float stock
PALI has all the right ingredients for a multi bagger
Low Float PALI Stock Buyers Drive Up Its Price So High.
Palisade Bio Inc ""MAPA 16 A "" Make PALI $16 A 🚀🚀🇺🇲💵🚀🚀🚀
PALI - 8% since alerted. Offering closed @ .25! AH DELIGHT
PALI - update 8% since alerted! Ready to RUN AH PM
PALI - easy to move, low float - let’s get it!
PALI - 72 million outstanding on a .16 stock? Volume rising?
I'll avoid the Hype . PALI .18 now before the 🚀🚀😎
$PALI - Palisade Bio Short action 24 march 2022
$PALI PALI's MACD Histogram just turned positive on January 07, 2022. A small recap for who missed it. No financial Advice....Please do your own DD
$PALI PALI's MACD Histogram just turned positive on January 07, 2022. A small recap for who missed it. No financial Advice....Please do your own DD
$PALI Palisade Bio Inc (PALI) Stock was analyzed by 7 analysts. The buy consensus is at 83%. So analysts seem to be very confident about $PALI Analysts have set a mean price target of 7.14. This target is 671.56% above the current price......No Financial Advice.... Do Your own DD
PALI is providing a dip now and I like to take a long position here.
Well now, didn't realiza this many patents were registered in $PALI. Mexico, Taiwan, Japan, Austrailia...lots
If the DOJ investigation becomes productive, eyes on $PALI and $RELI could be lucrative.
This is what it looks like when you say the truth on reddit...and just proves everything I have been saying about $PALI. Do funds hire firms to control sentiment? Yup. Do they go on downvoting rampages on reddit to do it? Yup
So you like RELI? Well, it has a friend. PALI also had ftd creation May 17th. Both shorted the same day in May. PALI with very good pr releases should be on your radar. Too many reasons to explain here. Let"s just say the DOJ might be curious if they dug deeper. No insider selling in $PALI to date
Well let's see what happens. $PALI accumulating. Borrow fee's remain high. Another 2 weeks of momentum expected. Sentiment looking good.
Looks like the accumulation that happened last week is continuing in PALI. Possibly some news to be released.
$PALI Held it's friday high. Still retaining it's 75%+ borrow fees.
FYI ladies...$PALI will surprise you very very soon. Notice of effectiveness filed yesterday to resell these shares. Oh yeah...and NON-DILLUTIVE. Yup, you're welcome. 1.5 million share purchase incoming
PALI Technical indicators up across the board. Oversold, ratio up, 20ma above 50ma. Sentiment up. Bio stocks all running hotter
$PALI Ratio shot up from 3.5 to 5.8. After dropping nsi-566 liabilities, rsi oversold, 2 patents, positive topline phase 2, 20ma crossing 50ma...nearly every sentiment is positive.
$PALI Bigtime sentiment bump. I am definitely one hundred and one percent bullish. Effective yesterday
Call me crazy. $PALI looking to finally run. Borrow fees still in the 75% range. Heavy dark pool shorting. Plenty of bullish indicators for longs
Been in $PALI since July. Looking like sum action coming in 🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀
Positive sentiment is going crazy in PALI. 2 patents granted in the last week. Solid bullish indicators. More links in comments.
Always gotta follow the sentiment. Positive bullish sentiment climbing fast in PALI. When you get 2 patents granted within 1 week, you know commercialization is in their sites. More info in comments
$PALI Positive sentiment climbing fast. 2 patents granted. Are you ready?
$PALI Sentiment climbing more since last update. This could be it.
$PALI Sentiment climbing pretty fast this week. 2 patents granted in one week is huge
$PALI Sentiment is starting to climb. Getting hot in here
No way the suppression in $PALI can last. You don't get 2 patents granted in one week and maintain your short for long
Sorry...not sorry. $PALI getting 2 patents granted in one week is all a long needs to know.
$PALI Well, we got our patents granted. We're not selling.
$PALI FYI. Stocktwits are short, and worse yet...liars trying to convince you to sell. You don't sell when you get a U.S. patent approval.
I've been in PALI for almost year now, stuck with them after a merger and a sharp decline. What's going on there?
$PALI U.S. patent for LB1148 granted TODAY. Links in the comments. This secures commercialization well into the 2030's. Phase 3 update expected any day
$PALI U.S. patent for LB1148 granted TODAY. Links in the comments. This secures commercialization well into the 2030's. Phase 3 update expected any day
$PALI U.S. patent granted TODAY. That pretty much secures commercialization in the EU and U.S. into 2030's
Ticker $PALI ------ Release from the company 07 december 2021
The screenshots PALI shorters don't want you to see. The moment I found the spac info, the web link was cut. That's when you know you're on to something
The screenshots PALI shorters do not want you to see. Just a helping hand connecting the dots
This is the screenshot PALI shorters don't want you to see
This is the screenshot $PALI shorters don't want you to see
Here's the screenshot of that website. They took it down today. What are they afraid of? Afraid retail will load up $PALI I think
I was gonna do a write up, but this sums up my findings. $PALI merger rumors increasing with $MSAC. This explains the maxim $7 pt. All the sp movements. Other bio's mentioned to be involved. This looks like the smoking gun
I was gonna do a write up, but this sums it up. $PALI sentiment just reversed. Merger rumors with $MSAC increasing. Other bio's mentioned. This explains the maxim $7 pt. The sp movements. This appears to be the smoking gun
The plot thickens in $PALI. The head of $MSAC is Eric Cheng. Who just happened to also be with Mxim Group. Who just also happens to have a $7 pt for $PALI. More dots connecting
$MSAC and $PALI. Smoking gun possibly found. This explains the maxim $7 pt
$PALI and $MSAC. Rumors starting to circulate
$PALI $MSAC Spac sponsored by Altium. Maxim involved in both as an analyst AND a holder
$PALI Call me crazy. What would the off chance be a company would be deliberately devalued to allow a discount acquisition by a spac?
$PALI Stumbled onto something. Could be something. Could be nothing. MSAC spac. Ever heard of companies being deliberately devalued to allow discounts pre-acquisition?
Let's be real. The market is red this week. Nothing will move up till Monday. So I'll be the first to say don't buy $PALI..don't buy a damn thing. Just don't. Wait. Let monday show itself first. Nothing is what it seems
Somethings up. No SI reported on fintel for dec 2nd, yet it most definitely had to be 80-100k more in $PALI. I know the lack of reporting is market wide, still, I'm not seeing suppression today. I think december is the turning point
A few bags of fresh fruit. Some apples, some oranges, and especially some bananas. How do you like your juice in the morning?
$PALI Yuma Regional large institutional investor for Palisade Bio. Yuma and Lifepoint (for profit) in merger talks. Apollo Global owns Lifepoint. Connect those dots. Add in upcoming Phase 3 pr. That's some serious investment capital
$PALI Just found this today. This is what flows through Yuma Regional (Palisade Bio partner). If/when Yuma and Lifepoint (for profit) merge, big moves are bound to happen. Apollo Global owns Lifepoint. That's some serious investment capital
$PALI Literally just saw this. This is what flows through Yuma Regional Medical Palisade Bio partner). If/when Lifepoint (for profit) merges with Yuma, I'd not be surprised something big occurs. 500 million in assets...WOW.
WOW. Just WOW. This is what flows through Yuma Regional Medical. Fully connected to $PALI. If/when Lifepoint(for profit) merges with Yuma, it'll be a upwards kaboom to say the least. It's time for some emoji's 🍌🍌🍌🍌🍌🍌🍌🍌🍌🍌🍌🍌🍌🍌🍌🍌🍌🍌🍌🍌🍌🍌🍌🍌🍌🍌🍌🍌🍌🍌🍌🍌🍌🍌🍌🍌🍌🍌🍌🍌🍌🍌
$PALI Pretty big volume spike pre-market. Insiders continue to load. Investor Observer just posted a buy rating yesterday. Now that's 2 analysts giving them bullish sentiment
$PALI New EU patent granted. Volume picked up bigtime pre-market. 2 analysts now have bullish and buy ratings. Phase 3 update should be heading in literally any day now.
Dare I say it, $PALI actually has VOLUME premarket. Never happened before.
$PALI Actually has a shot. Fully recovered from yesterday.
$PALI What makes PALI a smart short squeeze? No options. No puts. Good old fashioned buy and hold. 80% borrow fees got your back. The shorts are there. Buried in those dark pools.
$PALI Look at the shorters piling in. This is as good an opportunity as any to pounce. Borrow rate still above 80%. Even now has 2 analyst buy ratings to back the pressure up. Shorters are being bold and bragging today. They can be punished
$PALI Got it's second bullish rating listed today. Now that's 2 buy ratings by analysts
$PALI Just got it's 2nd bullish rating listed today. Now there's 2 analysts rating $PALI as a buy.
$PALI Look no further than stocktwits to find the short sellers listing lol
$PALI Fresh mini new DD up and running. A road map to guide your journey
Shiny and fresh new mini $PALI DD. Added some insight to help guide the journey
New and improved mini $PALI DD up and ready. Faith young grasshopper
Here you go, the new improved mini DD for $PALI. Added better insight to further guide the journey
A much better compacted mini DD for $PALI. Added some better insight to help guide the journey.
$PALI Mini new DD for recent events. Positive indicators for Phase 3 full trial commencement soon. Topline Phase 2 should be announced literally any day now. New hires brought in.
$PALI Now that the EU patent is granted, Phase 3 update should hit any day now. Semi new DD in comments
$PALI Will get a lot more interest now that the EU patent got granted today. I would expect a phase 3 pr any moment now
Mentions
PALI looks like a good long term…gonna get in on that one. Might mess with WORK or RVYL this morning. Thanks
Premarket Watchlist : **$RVYL** : Tiny float /Merger **$DRCT** : tiny float strong momentum. **$WORX** **$BURU** : known runner on hype, some news. Mid term : **$EONR** , **$INDO** : Iran : [https://www.reddit.com/r/pennystocks/s/zAdaGO700w](https://www.reddit.com/r/pennystocks/s/zAdaGO700w) **$NFE** : Blackrock 13G , 35% shorted : [https://www.sec.gov/Archives/edgar/data/1749723/000201238326000777/xslSCHEDULE\_13G\_X01/primary\_doc.xml](https://www.sec.gov/Archives/edgar/data/1749723/000201238326000777/xslSCHEDULE_13G_X01/primary_doc.xml) **$MYNZ** : Insiders buying, catalyst Q1 **$PALI** : catalyst Friday 23 https://preview.redd.it/canadn83p1fg1.jpeg?width=1320&format=pjpg&auto=webp&s=ab41a86468f03a79b11eaae5522281f8e8fa5742
Come on guys, $PALI BABY
All I'm going to say is $PALI
I found one mf that commented an article about PALI: NASDAQ having positive result trials for Ulcerative Colitis. Did my own due diligence and bought. My sister has it, and it’s an incurable disease. So a well worthy cause imo Currently up ~200% on my small position. Only time someone’s comment/post directly led to an investment, and it only influenced me because they posted the article directly.
Ok so like, how about we pump PALI and call it a day?
damn PALI chill i can only get so hard
How did we all miss PALI? feels like I didn’t see a thing in the last 3 weeks
Why do the stocks that come up on my screener never consist of whats being pushed here? Webull screener; Region: United States Last price: $0-2 Volume: 5 million and up Free float: 10 million and under CHR WORX PALI GIPR EZGO BLMZ BENF
Like this is the most steady upwards motion for PALI
Like this is the most steady upwards motion for PALI
PALI. my god that jump….💕💕💕
Im telling yall, PALI is about to fly up another 80%
im jumping in on PALI
Ok but hear me out, PALI has a call with investors tomorrow with 100% efficacy
$PALI Positive study results https://finviz.com/news/168367/palisade-bio-reports-positive-pali-2108-phase-1b-clinical-data
It was not my intention to artificially pump or dump the stock if you actually read my posts. I said that crypto news would come out soon, which didn't happen yet. I'm still proudly holding. You should stop making false claims kiddo. Ever saw my $PHIO and $PALI +100% predictions that went super well? Clearly you haven done you DD before attacking me
Making imaginary criterias? If you take a look back at my profile, you can clearly see that my account has many successful posts that made other people gain money ($PHIO, $MBOT, $PALI). There posts are clearly not AI generated, so why are pissed?
Here’s my recap: IMG led the way—smashed the 0.40 long trigger, hit 0.69, that’s a 72.5% long move PALI followed with 27.5% long move BRLT brought in 25.9% long move The whole ai bot farm thing is starting to work out after losing a crap-ton on its trades the last few months
What’s the deal with $PALI? Gonna keep dumping or should I buy in.
PALI was shorted heavily today on seemingly good news. The ingredients are there for a short squeeze. Earnings report on August 11th. Might be something to keep and eye on
PALI has plummeted completely lol Maybe someone was playing around with the stock price?
Made a quick buck on PALI the first five minutes
PALI has a 10x to 16x potential in the next 1-2 year(s). They are securing a patent expiring 2045 for their ongoing drug devlopment. Small market cap (~5M) so huge price swings and good entry point right now
if you want 10x bag for early 2026, load up on $PALI
Out on PALI today at 1.40. Hit my take profit. In on ADIL. Looking for a move up to $1.
Yes, you can ask these questions in the lounge. Personally, I would go all in on $MBOT, $PALI and $PHIO
Yes, but $PALI $PHIO are definitely to watch, and $MBOT too if they get FDA approval
$PALI, $PHIO and $MBOT if they get FDA approval
Thank you! Any further investors in PALI? Sounds interesting\~!
Anyone know what upcoming catalysts PALI has? I keep seeing it recommended and it’s gone up a bunch but I have no idea why people are still buying
$MBOT + $PALI for quick money
Made big money on $PALI, can't wait for it to go up again next week!
PALI i dont say it enough, thank me later
I sold PALI and OPEN. These aren't my stocks it's a screenshot from and AI analysis website
Yes sir, you should take a look at my new post. In there you'll see $PALI
PALI with a market cap of 5.6M and upcomming phase two, potential 10 bagger
What about Palisade Bio Inc NASDAQ: PALI
My play in PALI worked out today. Keeping a close eye on it to re-enter.
Is PALI worth putting money into
I'm in on PALI for a play. Chart is primed.
Someone made a post about PALI yesterday. It’s moving up rn
Giiant pharma are not listed. Their activities are supported by supported by a $500,000 grant received from the US Crohn’s and Colitis Foundation, through its IBD Ventures program. More on funding: In **May 2024**, the company raised approximately **$4 million** via a private placement led by Ladenburg Thalmann, explicitly earmarked for PALI‑2108 development and working capital in **December 2024**, they completed an **underwritten public offering**, securing about **$5 million** from new common shares and warrants—proceeds earmarked for clinical trials, R&D, and working capital Through their Giiant Pharma co‑development, Palisade received **CAD$1.39 million** from Canada’s SR&ED tax credit (early 2025), reimbursing preclinical development expenses for PALI‑2108 This stock will most likely increase the release of more data. They might need to dilute, my hunch is they could get non-dilutive grants. I might be useful to listen on their earnings call (if they have one).
Executive Summary Palisade Bio is advancing PALI-2108, a novel, orally administered, colon-specific phosphodiesterase-4 (PDE4) inhibitor prodrug for the treatment of ulcerative colitis (UC). The company has recently reported positive topline results from its Phase 1a clinical trial and is proceeding with a Phase 1b study. Financially, the company is in a precarious position, with a limited cash runway that will necessitate additional funding in the near future. The management team, however, brings relevant experience in drug development and financial management. The competitive landscape for IBD is crowded, but PALI-2108's targeted delivery mechanism could offer a key differentiator. The success of Palisade Bio hinges on the continued clinical advancement of PALI-2108 and the company's ability to secure the necessary capital to fund its operations. Financial Analysis: A Precarious Path Forward A thorough review of Palisade Bio's SEC filings paints a picture of a company with a critical need for capital. As of the latest quarterly report for the period ending March 31, 2025, the company's financial position is characterized by: * Limited Cash Runway: While specific current cash on hand is not publicly available, analysis of past burn rates and recent financing activities suggests a limited operational runway. The company will need to secure additional funding to advance PALI-2108 through further clinical trials. * Recent Financing: In December 2024, Palisade Bio closed a $5 million underwritten public offering. Such financing activities, while necessary for survival, can lead to shareholder dilution. * Negative Earnings: As a clinical-stage company with no commercial products, Palisade Bio has a history of negative earnings per share (EPS). This is typical for the sector but underscores the long road to potential profitability. Investors should closely monitor the company's cash burn rate and any future financing announcements, as these will be critical determinants of its viability. Clinical Pipeline: PALI-2108 Shows Early Promise Palisade Bio's clinical pipeline is currently centered on a single asset, PALI-2108. * PALI-2108 for Ulcerative Colitis: This oral PDE4 inhibitor is designed as a prodrug, meaning it becomes active only when it reaches the colon. This targeted approach aims to minimize the systemic side effects, such as nausea and vomiting, that have plagued other oral PDE4 inhibitors. * Positive Phase 1a Results: In May 2025, the company announced positive topline results from its Phase 1a single-ascending dose trial of PALI-2108 in healthy volunteers. The drug was reported to be well-tolerated and demonstrated the intended colon-specific activity. * Phase 1b Underway: Following the successful Phase 1a, Palisade Bio has initiated a Phase 1b multiple-ascending dose study in patients with ulcerative colitis. The results from this trial will be a significant catalyst for the company. * Precision Medicine Approach: The company has entered into a collaboration with Strand Life Sciences to leverage bioinformatics and identify biomarkers that could predict patient response to PALI-2108. This precision medicine strategy could enhance the probability of success in later-stage trials. The early clinical data for PALI-2108 is encouraging, but the drug is still in the very early stages of development. The path to regulatory approval is long and fraught with potential setbacks. Management and Corporate Governance: Experienced Leadership at the Helm Palisade Bio is led by a management team with experience in both the scientific and financial aspects of the biopharmaceutical industry. * JD Finley, Chief Executive Officer: Mr. Finley has a background in finance and has been instrumental in securing capital for the company. His financial acumen will be crucial as Palisade Bio navigates its current financial challenges. * Mitchell Jones, MD, PhD, Chief Medical Officer: Dr. Jones brings extensive experience in gastroenterology and clinical development. His expertise will be vital in guiding the clinical strategy for PALI-2108. * Recent Board Addition: In July 2025, the company appointed Emil Chuang, MB BS FRACP, to its Board of Directors. Dr. Chuang has a track record of successful clinical development in IBD, further strengthening the company's expertise in its target therapeutic area. The experience of the management team and board provides a degree of confidence in the company's ability to execute its clinical and financial strategies. Competitive Landscape: A Crowded Field with a Niche Opportunity The market for IBD treatments is a multi-billion dollar industry dominated by large pharmaceutical companies with established biologic therapies. However, there is a significant unmet need for safe and effective oral treatments. * Direct Competitors: The oral PDE4 inhibitor space for IBD includes other companies in various stages of clinical development. A key differentiator for Palisade Bio will be to demonstrate a superior safety and efficacy profile for PALI-2108, leveraging its colon-targeted mechanism. * Broader Competition: Beyond other PDE4 inhibitors, PALI-2108 will compete with a wide array of oral and injectable therapies with different mechanisms of action. Palisade Bio's success will depend on its ability to carve out a niche for PALI-2108 by proving a tangible clinical benefit, particularly in terms of safety, over existing and emerging therapies. Conclusion: High-Risk, High-Reward Proposition Investing in Palisade Bio at its current stage is a speculative endeavor with the potential for significant returns, but also the risk of substantial loss. The company's future is almost entirely dependent on the successful clinical development and eventual commercialization of PALI-2108. Key catalysts for investors to watch include: * Results from the ongoing Phase 1b trial of PALI-2108. * Announcements of any new financing activities. * Updates on the collaboration with Strand Life Sciences and the development of a biomarker strategy. * Initiation of a Phase 2 clinical trial for PALI-2108.
found $PALI earlier this week, currently trading close ATL 0.75$ and many analysts place it at around 10,6$ average to 16$. dd intended
PALI sellers have control and are waiting on volume. Coiled like a MOFO
PALI is trading under $2/share. All the 12 month forecasts that I have read are a minimum of $12, all the way to $38. At this price, you can apparently at least quadruple your money with some patience.
!banbet PALI 1.85 2w
**Top pre-market gainers:** $LIPO +226% $NLSP +71% $YIBO +45% $PALI +41% $TIVC +24% **Top pre-market losers:** $NAMS -25% $CERO -23% $IART -22% $WINT -21% LUXH -17%
Only down 15% with AKBA? I also have FGEN, PALI, and VTGN.
Still room for $PALI to keep going today 👍🏻👍🏻
I am clearly a stupid trader and need help; I bought 6.3K shares worth of PALI at $1.59 and put a stop loss at $1.48. It hit my stop loss ($1.48), but not even 30 minutes later, it skyrocketed to $1.93. Can someone please tell me how to read charts better or how not to panic? Or give tips or tricks on how to be a better trader? I don't know if I'm following my own rules right or not, as well. Any insight would be greatly appreciated. Thank you!
PALI, TRKA, SMFL, SONN, SHPH, XELA These are going to pop, is my analysis. Not financial advice.
PALI got a $50 PT last week and didnt even make it to $4 before another offering and tanked lol.
PALI FFIE PXMD GFAI top watches tomorrow:)
Here's what I learned from day trading: I didn't need to trade many stocks everyday. I traded a total of 10 stocks in the entire week (9 profitable, 1 loss). The one loss should've been a win, but I had a stop loss too close. I missed out on a lot of profit I should've made (PALI, VKTX, EBS). The reason I justify the lost potential is the stocks I managed to get out of for small profits (HUBC, PXMD, CDAK, and VORB) . Gains compile and grow, losses do too. I'm new to this trading style, so I will learn to expand profits, but so far my losing strategy is also in its infancy. I've managed to get great luck on all my stocks, but that won't continue. Congrats on the trade!
You might be looking at the wrong PALI
Hey all! Premarket has been weirdly uninteresting. Nothing of note really happened and nothing has really grabbed my attention. I think we're in for a pretty bad day. I personally will be watching S2 of Reacher because I'm not enthused at all about trading today. For what it's worth, the algo thinks I'm wrong. We have some stocks today. PXMD still not doing a lot during premarket and finally broke the pattern of "down at open, up by mid day, down at close" yesterday by just... staying down. A lot of people are concerned about the noticeable lack of volume today. I'd be concerned, too. FRC still here. Good morning, I'm expecting a bad day though. MCB is a surprise inclusion but has been looking okay. The smaller market cap makes it a little bit more fun than FRC, to me. PYXS, CRKN, INPX, and PALI have been good at times. Note the wording there. Have not been consistent at all and I think that'll continue during the day. I'm expecting some profit if you're scalping but you're going to want to be much more cautious than usual. Smaller but more frequent swings are my estimation of today. Best of luck and have a great weekend! I'll see you cool cats on Monday.
Have a small profit on crkn, thx you, i could have more but i miis the0.2 position, it was my mistake. So i sold everything before bell, however look on PALI will go huge tomorrow, but maybe it is just one day game.
Glad I got in NGL yesterday. Watching for re entry into HTGM, giving NVOS till Monday which is deadline for 10K and 10Q and waiting for PALI a little longer.
HTGM, PALI, NVOS and NGL for tomorrow
HTGM BTB PALI NVOS(last couple days)
Hoping PALI pops tomorrow and gonna double down on BTB when it dips
PALI BTB and holding NVOS and SYTA
PALI finally doing something thank fuck. Hopped out of HTGM, will get back in later in the week. BBT and Pali feeding me rn. Giving NVOS till Friday.
IVDA, HTGM, PALI and NVOS. May load up more on SYTA too
More HTGM, more PALI once it consolidates and watching NVOS
NVOS HTGM and PALI will pop this week
HTGM NVOS AND PALI will run this week.
HTGM, PALI NVOS as usual. Check out the chart for HTGM.
HTGM, PALI and more NVOS. Word to the wise if y’all see the same ticker being spammed in here hundreds of times, fade it. EBET fucked y’all today. Learn the lesson.
HTGM, PALI and more NVOS. Word to the wise if y’all see the same ticker being spammed in here hundreds of times, fade it. EBET fucked y’all today. Learn the lesson.
HTGM, PALI and more NVOS. Word to the wise if y’all see the same ticker being spammed in here hundreds of times, fade it. EBET fucked y’all today. Learn the lesson.